During this period, individuals may experience a gradual reduction in appetite, contributing to weight loss ranging from 3% to 5% of body weight, depending on personal factors
In addition, it is related to a decrease in food consumption and growth rate, and nervous signs of varying intensities may be observed
Moreover, in subjects with diabetes who were at high risk of cardiovascular events, treatment with GLP-1R agonists based on the structure of endogenous GLP-1, namely liraglutide, semaglutide, albiglutide, and dulaglutide, has demonstrated reductions in major adverse cardiovascular events (MACEs) that appear to be unrelated to the glycemic effects of these agents (1316)

You should seek medical advice if you experience: Severe or persistent sore throat lasting more than a few days without improvement Difficulty swallowing (dysphagia) or pain when swallowing (odynophagia), which may suggest oesophageal inflammation or infection and warrants urgent referral to exclude cancer (in line with NICE guidance NG12) Breathing difficulties or stridor (a high-pitched sound when breathing) call 999 immediately as this could indicate airway obstruction or severe allergic reaction High fever (above 38C) accompanied by sore throat, which may suggest bacterial infection requiring antibiotic treatment Swelling of the face, lips, tongue, or throat call 999 immediately as this could indicate angioedema, a potentially life-threatening allergic reaction Persistent hoarseness or voice changes lasting more than three weeks Blood in saliva or phlegm If you suspect your throat symptoms are related to severe reflux or oesophagitis , particularly if accompanied by chest pain, difficulty swallowing, or unintentional weight loss, your GP may refer you for further investigation, such as endoscopy, in line with NICE guidance on dyspepsia and GORD

Deconstructing the Gastrointestinal Repair Mechanisms While BPC-157 exhibits systemic protective effects, its most extensively studied applications are within the gastrointestinal (GI) tract